Article Versions Notes

Krivdić Dupan Z, Periša V, Suver Stević M, Mihalj M, Tolušić Levak M, Guljaš S, Salha T, Loinjak D, Kos M, Šapina M, et al. The Impact of Pentraxin 3 Serum Levels and Angiotensin-Converting Enzyme Polymorphism on Pulmonary Infiltrates and Mortality in COVID-19 Patients. Biomedicines. 2024; 12(7):1618. https://doi.org/10.3390/biomedicines12071618

Krivdić Dupan, Zdravka, Vlatka Periša, Mirjana Suver Stević, Martina Mihalj, Maja Tolušić Levak, Silva Guljaš, Tamer Salha, Domagoj Loinjak, Martina Kos, Matej Šapina, and et al. 2024. "The Impact of Pentraxin 3 Serum Levels and Angiotensin-Converting Enzyme Polymorphism on Pulmonary Infiltrates and Mortality in COVID-19 Patients" Biomedicines 12, no. 7: 1618. https://doi.org/10.3390/biomedicines12071618

Krivdić Dupan, Z., Periša, V., Suver Stević, M., Mihalj, M., Tolušić Levak, M., Guljaš, S., Salha, T., Loinjak, D., Kos, M., Šapina, M., Canjko, I., Šambić Penc, M., Štefančić, M., & Nešković, N. (2024). The Impact of Pentraxin 3 Serum Levels and Angiotensin-Converting Enzyme Polymorphism on Pulmonary Infiltrates and Mortality in COVID-19 Patients. Biomedicines, 12(7), 1618. https://doi.org/10.3390/biomedicines12071618